The use of drug delivery systems to overcome biological barriers for improved safety and efficacy of nervous system therapeutics is an increasingly critical and evolving field. Controlled release systems have been employed to improve the effectiveness of gene delivery, reformulate existing drugs, and design new drugs to meet the high potential for patient benefit. The Nervous System Delivery (NSD) Focus Group will support the CRS mission by engaging researchers, clinicians, industry representatives, and regulatory experts in the advancement of technologies designed for attenuation, protection, repair, and regeneration of brain, spinal, and peripheral nervous system diseases.
The members of the Focus Group are expected to be paid members of CRS, independent of their membership category.
Do you have an NSD-related announcement (recent publication, award, upcoming talk, promotion, etc.) that you would like highlighted on Twitter? Share with us here: https://forms.gle/tcDpv78CadfMrreQ9"
Fill out this form if you would like to join our Member Feature series on Twitter: https://forms.gle/rbVptYPDkhQVa2Yt5
Leadership:
